MicroRNAs in Metastasis and the Tumour Microenvironment

Carla Solé1, Charles Henderson Lawrie1,2,3

  • 1Molecular Oncology Group, Biodonostia Research Institute, 20014 San Sebastian, Spain.

Insights

This review highlights how microRNAs (miRNAs) mediate communication between tumor and non-tumoral cells within the tumor microenvironment (TME). Understanding these miRNA roles in extracellular vesicles (EVs) is crucial for combating cancer metastasis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Metastasis is the primary cause of cancer mortality, with half of patients diagnosed with metastatic disease.
  • MicroRNAs (miRNAs) are key regulators of gene expression involved in cancer progression and metastasis.
  • Tumor cell communication with the tumor microenvironment (TME) is critical for metastasis.

Purpose of the Study:

  • To review the role of microRNAs (miRNAs) in intercellular communication within the tumor microenvironment (TME).
  • To highlight the importance of circulating miRNAs within extracellular vesicles (EVs) in mediating pre-metastatic and metastatic niche formation.
  • To underscore the need for better understanding of miRNA functions to develop anti-metastasis strategies.

Main Methods:

  • Literature review of existing research on microRNAs, extracellular vesicles, and cancer metastasis.
  • Analysis of evidence detailing miRNA involvement in tumor cell-TME interactions.
  • Synthesis of findings related to miRNA-mediated communication in pre-metastatic and metastatic niche development.

Main Results:

  • Accumulating evidence demonstrates miRNAs are crucial mediators of communication between tumor cells and TME components.
  • Extracellular vesicles (EVs) are significant carriers of circulating miRNAs involved in this intercellular dialogue.
  • miRNAs play a vital role in establishing both pre-metastatic and established metastatic niches.

Conclusions:

  • MicroRNAs are central players in the complex communication networks that drive cancer metastasis.
  • Targeting miRNA-mediated intercellular communication, particularly via EVs, offers potential therapeutic avenues.
  • Further research into miRNA functions in the TME is essential for developing novel anti-metastasis therapies.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.1K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.9K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
22.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.2K